Posaconazole Tablet, Coated
Product Images NDC 72205-168

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 72205-168). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pos-dr-tab-100mg-60s-count-cntr-label (Pos Dr Tab 100mg 60s Count Cntr Label)

Pos-dr-tab-100mg-60s-count-cntr-label (Pos Dr Tab 100mg 60s Count Cntr Label)
Label for Posaconazole Delayed-Release Tablets, 100 mg, coated oral tablets in a bottle of 60 tablets. The label includes storage instructions, manufacturer MSN Laboratories Private Limited in India, and distributor Novadoz Pharmaceuticals LLC, Piscataway, NJ. The label mentions these tablets are not interchangeable with Posaconazole oral suspension.*
FDA Label Image

Pos-dr-tab-structure (Pos Dr Tab Structure)

Pos-dr-tab-structure (Pos Dr Tab Structure)
Chemical structure of posaconazole, a triazole antifungal compound, showing its characteristic ring systems and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.